G. Poochikian

发表

Development and Approval of Inhaled Respiratory Drugs: A US Regulatory Science Perspective

G. Singh, G. Poochikian, 2011 .

Role of pharmacokinetics in establishing bioequivalence for orally inhaled drug products: workshop summary report.

A. Fuglsang, S. Lee, H. Derendorf, 2011, Journal of aerosol medicine and pulmonary drug delivery.

Regulatory aspects of modifications to innovator bronchodilator metered dose inhalers and development of generic substitutes.

G. P. Burke, A. S. Taylor, R. Williams, 1994, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

Enhanced chartreusin solubility by hydroxybenzoate hydrotropy.

J. Cradock, G. Poochikian, 1979, Journal of pharmaceutical sciences.

Diethyl (4baalpha,4calpha,9aalpha,9balpha)-3,6-dichlorocyclobuta[1,2-b:3,4-b']bisbenzofuran-9a,9b(4bH,4cH)-dicarboxylate: the cis,syn photodimer of ethyl 5-chlorobenzofuran-2-carboxylate, an analogue related to the antilipidemic drug clofibrate.

D. Witiak, J. Baldwin, H. A. Newman, 1978, Journal of medicinal chemistry.

Comparative antilipidemic effects of various ethyl 5-substituted benzofuran-, 2,3-dihydrobenzofuran-, and 3(2H)-benzofuranone-2-carboxylate analogs of clofibrate in a triton hyperlipidemic rat model

D. Witiak, H. A. Newman, W. Loh, 1976, Lipids.

Pharmaceutical Solids: A Strategic Approach to Regulatory Considerations

Stephen Byrn, Michael Ganey, S. Byrn, 1995, Pharmaceutical Research.

Simple high-performance liquid chromatographic method for the separation of 3,6-diacetylmorphine hydrochloride (heroin) and hydrolysis products.

J. Cradock, G. Poochikian, 1979, Journal of chromatography.

Stability of anthracycline antitumor agents in four infusion fluids.

J. Cradock, K. Flora, G. Poochikian, 1981, American journal of hospital pharmacy.

2,5-Diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone II: Isolation and characterization of degradation products.

J. Kelley, G. Poochikian, 1981, Journal of pharmaceutical sciences.

Best Practices for Extractables and Leachables in Orally Inhaled and Nasal Drug Products: An Overview of the PQRI Recommendations

Fran DeGrazio, Diane Paskiet, D. Norwood, 2008, Pharmaceutical Research.

Determination of ellipticine in biological samples by high-performance liquid chromatography.

J. Cradock, K. Flora, G. Poochikian, 1982, Journal of chromatography.

Differential effects of benzodioxane, chroman, and dihydrobenzofuran analogs of clofibrate on various parameters of hepatic drug metabolism.

D. Witiak, N. Lewis, D. Feller, 1974, Journal of medicinal chemistry.

Heroin: Stability and formulation approaches

J. Davignon, J. Cradock, G. Poochikian, 1983 .

2,5-Diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone I: Kinetics in aqueous solutions by high-performance liquid chromatography.

J. Cradock, G. Poochikian, 1981, Journal of pharmaceutical sciences.

Content Uniformity and Dose Uniformity: Current Approaches, Statistical Analyses, and Presentation of an Alternative Approach, with Special Reference to Oral Inhalation and Nasal Drug Products

Walter W. Hauck, Wallace P. Adams, W. Hauck, 2002, Pharmaceutical Research.

9-Chloro-2,3-dihydro-5H-1,4-dioxepino(6,5-b)benzofuran, a novel antilipidemic agent structurally related to clofibrate.

D. Witiak, H. A. Newman, D. Feller, 1975, Journal of medicinal chemistry.

9-CHLORO-2,3-DIHYDRO-5H-1,4-DIOXEPINO(6,5-B)BENZOFURAN, A NOVEL ANTILIPIDEMIC AGENT STRUCTURALLY RELATED TO CLOFIBRATE

D. Witiak, H. A. Newman, D. Feller, 1976 .